Your browser doesn't support javascript.
loading
A comprehensive study of immune function and immunophenotyping of white blood cells from ß-thalassaemia/HbE patients on hydroxyurea supports the safety of the drug.
Siriworadetkun, Sirikwan; Thiengtavor, Chayada; Thubthed, Rattanawan; Paiboonsukwong, Kittiphong; Fucharoen, Suthat; Pattanapanyasat, Kovit; Vadolas, Jim; Svasti, Saovaros; Chaichompoo, Pornthip.
Afiliação
  • Siriworadetkun S; Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.
  • Thiengtavor C; Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
  • Thubthed R; Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
  • Paiboonsukwong K; Faculty of Optometry, Ramkhamhaeng University, Bangkok, Thailand.
  • Fucharoen S; Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
  • Pattanapanyasat K; Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.
  • Vadolas J; Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.
  • Svasti S; Siriraj Centre of Research Excellence for Microparticle and Exosome in Diseases, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Chaichompoo P; Centre for Cancer Research, Hudson Institute of Medical Research, Melbourne, Australia.
Br J Haematol ; 200(3): 367-376, 2023 02.
Article em En | MEDLINE | ID: mdl-36221231

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talassemia beta / Hidroxiureia Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talassemia beta / Hidroxiureia Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article